SANGAMO THERAPEUTICS
Sangamo Therapeutics is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The company's product pipeline includes Hemophilia, Central Nervous System, HIV, Lysosomal Storage Disorders, and Hemoglobinopathies.
SANGAMO THERAPEUTICS
Industry:
Biotechnology Genetics Health Care Pharmaceutical Therapeutics
Founded:
1995-01-01
Address:
Richmond, California, United States
Country:
United States
Website Url:
http://www.sangamo.com
Total Employee:
251+
Status:
Active
Contact:
5102368951
Email Addresses:
[email protected]
Total Funding:
522.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Google Tag Manager WordPress Domain Not Resolving Wordpress Plugins Mobile Non Scaleable Content Nginx Sitelinks Search Box
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Agenus
Agenus develops and commercializes immunotherapies and vaccines for cancer and infectious diseases.
Altor BioScience
Altor BioScience researches and develops immunotherapeutic agents for the treatment of cancer, viral infections and autoimmune diseases.
Bluebird Bio
Bluebird Bio offers products based on the transformative potential of gene therapy for patients with genetic and orphan diseases.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-07-23 | TxCell | TxCell acquired by Sangamo Therapeutics | 72 M EUR |
| 2013-08-26 | Ceregene | Ceregene acquired by Sangamo Therapeutics | N/A |
Investors List
California Institute for Regenerative Medicine
California Institute for Regenerative Medicine investment in Grant - Sangamo Therapeutics
National Institutes of Health
National Institutes of Health investment in Grant - Sangamo Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2020-04-17 | Sangamo Appoints D. Mark McClung as Executive Vice President and Chief Business Officer |
Official Site Inspections
http://www.sangamo.com Semrush global rank: 2.16 M Semrush visits lastest month: 9.21 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Sangamo Therapeutics"
Sangamo Announces R&D Organization Changes | Sangamo …
Jun 24, 2020 The Investor Relations website contains information about Sangamo Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Meet Our Leadership | Sangamo Therapeutics, Inc.
Meet the Sangamo Therapeutics Management Team. Know our executive leadership team and board of directors here.See details»
Sangamo Therapeutics - Wikipedia
Sangamo Therapeutics, Inc. (previously known as Sangamo Biosciences, Inc.) is an American biotechnology company based in Brisbane, California. It applies cell and gene therapy to combat haemophilia and other genetic diseases. See details»
Our Mission | Sangamo Therapeutics, Inc.
Sangamo is a genomic medicine company that seeks to help millions of people who suffer from severe diseases for which today’s medicine can only offer symptom management at best. Our mission is to translate ground-breaking …See details»
Sangamo Therapeutics - Crunchbase Company Profile …
Sangamo Therapeutics is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and …See details»
Sangamo Therapeutics, Inc. | LinkedIn
For Sangamo Therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. Our scientists are leaders in the ...See details»
Environment | Social | Governance | Sangamo …
The Investor Relations website contains information about Sangamo Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Sangamo Announces R&D Organization Changes - Business Wire
Jun 24, 2020 Sangamo Therapeutics, Inc. (Nasdaq: SGMO) today announced changes to its research and development organization. Going forward, research and developmenSee details»
Sangamo Therapeutics, Inc. - Drug pipelines, Patents ... - Patsnap
Nov 1, 2024 Explore Sangamo Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 35 clinical trials, 220 news, and 268 literature, Disease Domain:Nervous …See details»
Sangamo Therapeutics Announces Strategic Update and Reports …
Nov 1, 2023 Sangamo Therapeutics Announces Strategic Update and Reports Third Quarter 2023 Financial Results Announced additional progress towards strategic transformation into …See details»
Sangamo Therapeutics - Funding, Financials, Valuation & Investors
Sangamo Therapeutics is funded by 2 investors. California Institute for Regenerative Medicine and National Institutes of Health are the most recent investors.See details»
Our Commitment to Serve Patients | Sangamo Therapeutics, Inc.
At Sangamo, we are committed to offering patients valuable information to support them along their journey. Explore our Patient Resources page for educational materials and a list of …See details»
Sangamo Therapeutics Company Profile - Craft
Sangamo Therapeutics (formerly known as Sangamo BioSciences) is a clinical-stage biopharmaceutical company focused on the research, development, and commercialization of …See details»
Sangamo Therapeutics Announces Global Epigenetic Regulation …
Aug 6, 2024 Agreementleverages Sangamo’s proprietary capsid delivery platform and epigenetic regulation capabilities to address certain neurodegenerative diseases Sangamo expected to …See details»
Careers | Join Sangamo| Sangamo Therapeutics, Inc.
Sangamo is a genomic medicine company that seeks to help millions of people who suffer from severe diseases for which today’s medicine can only offer symptom management at best. Our …See details»
Sangamo Therapeutics Reports Recent Business Highlights and …
Oct 20, 2022 The Investor Relations website contains information about Sangamo Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Sangamo Announces Evolved Corporate Values, Reflecting Growth …
As Sangamo continues to grow, it is important that our company values do the same. Our recently relaunched company values are reflective of Sangamo’s evolution as a leading genomic …See details»
Sangamo Therapeutics, Inc. (SGMO) - Yahoo Finance Canada
Find the latest Sangamo Therapeutics, Inc. (SGMO) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Sangamo Programs On Genomic Medicine | Sangamo …
We are pursuing programs across the spectrum of genomic medicine, with gene and cell therapies in the clinic today and preclinical programs in genome engineering.See details»